| Clinical significance of PD-L1 protein expression in surgically resected primary lung adenocarcinoma K Takada, T Okamoto, F Shoji, M Shimokawa, T Akamine, S Takamori, ... Journal of Thoracic Oncology 11 (11), 1879-1890, 2016 | 194 | 2016 |
| PD-L1 is upregulated by simultaneous amplification of the PD-L1 and JAK2 genes in non–small cell lung cancer S Ikeda, T Okamoto, S Okano, Y Umemoto, T Tagawa, Y Morodomi, ... Journal of Thoracic Oncology 11 (1), 62-71, 2016 | 174 | 2016 |
| Clinical implications of sarcopenia in patients undergoing complete resection for early non-small cell lung cancer Y Suzuki, T Okamoto, T Fujishita, M Katsura, T Akamine, S Takamori, ... Lung cancer 101, 92-97, 2016 | 129 | 2016 |
| Predictive impact for postoperative recurrence using the preoperative prognostic nutritional index in pathological stage I non-small cell lung cancer F Shoji, Y Morodomi, T Akamine, S Takamori, M Katsura, K Takada, ... Lung Cancer 98, 15-21, 2016 | 100 | 2016 |
| Prognostic impact of local treatment against postoperative oligometastases in non‐small cell lung cancer T Yano, A Haro, T Yoshida, Y Morodomi, K Ito, Y Shikada, F Shoji, ... Journal of surgical oncology 102 (7), 852-855, 2010 | 79 | 2010 |
| Nanomedicines Eradicating Cancer Stem-like Cells in Vivo by pH-Triggered Intracellular Cooperative Action of Loaded Drugs H Kinoh, Y Miura, T Chida, X Liu, K Mizuno, S Fukushima, Y Morodomi, ... ACS nano 10 (6), 5643-5655, 2016 | 72 | 2016 |
| Prognostic significance of intratumoral blood vessel invasion in pathologic stage IA non-small cell lung cancer F Shoji, A Haro, T Yoshida, K Ito, Y Morodomi, T Yano, Y Maehara The Annals of thoracic surgery 89 (3), 864-869, 2010 | 70 | 2010 |
| First case of combined small-cell lung cancer with adenocarcinoma harboring EML4-ALK fusion and an exon 19 EGFR mutation in each histological component G Toyokawa, K Taguchi, T Ohba, Y Morodomi, T Takenaka, F Hirai, ... Journal of Thoracic Oncology 7 (12), e39-e41, 2012 | 52 | 2012 |
| Clinicopathological significance of Sip1-associated epithelial mesenchymal transition in non-small cell lung cancer progression N Miura, T Yano, F Shoji, D Kawano, T Takenaka, K Ito, Y Morodomi, ... Anticancer research 29 (10), 4099-4106, 2009 | 51 | 2009 |
| Tyrosyl-tRNA synthetase stimulates thrombopoietin-independent hematopoiesis accelerating recovery from thrombocytopenia T Kanaji, MN Vo, S Kanaji, A Zarpellon, R Shapiro, Y Morodomi, ... Proceedings of the National Academy of Sciences 115 (35), E8228-E8235, 2018 | 43 | 2018 |
| Serum antioxidant capacity and oxidative injury to pulmonary DNA in never-smokers with primary lung cancer K Ito, T Yano, Y Morodomi, T Yoshida, M Kohno, A Haro, Y Shikada, ... Anticancer research 32 (3), 1063-1067, 2012 | 42 | 2012 |
| Correlation between CXCR4/CXCR7/CXCL12 chemokine axis expression and prognosis in lymph‐node‐positive lung cancer patients M Katsura, F Shoji, T Okamoto, S Shimamatsu, F Hirai, G Toyokawa, ... Cancer Science 109 (1), 154-165, 2018 | 41 | 2018 |
| The prognostic impact of the amount of tobacco smoking in non-small cell lung cancer—differences between adenocarcinoma and squamous cell carcinoma T Okamoto, Y Suzuki, T Fujishita, H Kitahara, S Shimamatsu, M Kohno, ... Lung cancer 85 (2), 125-130, 2014 | 41 | 2014 |
| Impact of the epidermal growth factor receptor mutation status on the post-recurrence survival of patients with surgically resected non-small-cell lung cancer T Takenaka, M Takenoyama, M Yamaguchi, R Toyozawa, E Inamasu, ... European Journal of Cardio-Thoracic Surgery 47 (3), 550-555, 2015 | 38 | 2015 |
| Gemcitabine and vinorelbine as second-line or beyond treatment in patients with malignant pleural mesothelioma pretreated with platinum plus pemetrexed chemotherapy G Toyokawa, M Takenoyama, F Hirai, R Toyozawa, E Inamasu, M Kojo, ... International journal of clinical oncology 19, 601-606, 2014 | 36 | 2014 |
| Peritoneal dissemination requires an Sp1-dependent CXCR4/CXCL12 signaling axis and extracellular matrix–directed spheroid formation Y Kasagi, Y Harada, Y Morodomi, T Iwai, S Saito, K Yoshida, E Oki, ... Cancer research 76 (2), 347-357, 2016 | 35 | 2016 |
| Prediction of true-negative lymph node metastasis in clinical IA non-small cell lung cancer by measuring standardized uptake values on positron emission tomography T Takenaka, T Yano, Y Morodomi, K Ito, N Miura, D Kawano, F Shoji, ... Surgery today 42, 934-939, 2012 | 34 | 2012 |
| Repurposed drugs block toxin-driven platelet clearance by the hepatic Ashwell-Morell receptor to clear Staphylococcus aureus bacteremia J Sun, S Uchiyama, J Olson, Y Morodomi, I Cornax, N Ando, Y Kohno, ... Science translational medicine 13 (586), eabd6737, 2021 | 33 | 2021 |
| Clinical role of a new prognostic score using platelet-to-lymphocyte ratio in patients with malignant pleural mesothelioma undergoing extrapleural pneumonectomy T Tagawa, M Anraku, Y Morodomi, T Takenaka, T Okamoto, ... Journal of Thoracic Disease 7 (11), 1898, 2015 | 33 | 2015 |
| An extremely rare case of small-cell lung cancer harboring variant 2 of the EML4-ALK fusion gene G Toyokawa, M Takenoyama, K Taguchi, R Toyozawa, E Inamasu, ... Lung Cancer 81 (3), 487-490, 2013 | 33 | 2013 |
